Finecare™ CEA Rapid Quantitative Test is a fluorescence immunoassay for measuring carcinoembryonic antigen (CEA) in human whole blood, serum, and plasma. Used with compatible Finecare™ FIA Systems, it provides results in approximately 15 minutes to support treatment evaluation, prognosis, and recurrence monitoring.
Wondfo CA125 Rapid Quantitative Test is designed for quantitative measurement of the CA125 tumor marker in human serum, plasma, and whole blood. With a 75 μL sample requirement and approximately 10-minute reaction time, it supports ovarian cancer treatment monitoring and follow-up.
Wondfo CA15-3 Rapid Quantitative Test is designed for quantitative measurement of the CA15-3 tumor marker in human serum, plasma, and whole blood. With a 75 μL sample volume and approximately 10-minute reaction time, it supports breast cancer treatment monitoring and follow-up in professional laboratory settings.
Wondfo CA19-9 Rapid Quantitative Test is a CE-qualified in vitro diagnostic assay for quantitative measurement of CA19-9 in human serum, plasma, and whole blood. Requiring a 75 μL sample, it delivers results in approximately 10 minutes to support clinical assessment and monitoring workflows.
